Quintara Biosciences announces that it has completed the acquisition of Laragen Sanger Sequencing, formerly operated by Transnetyx, effective September 15, 2025. All Sanger Sequencing services previously offered by Laragen, including DNA Sequencing, Microbial Identification, and Cell Line Identification, will continue without disruption. Quintara Biosciences is a leading genomics and molecular biology CRO/CDMO providing comprehensive sequencing and molecular services to the biotech and academic research community.
Read the full article: Quintara Biosciences Completes Acquisition of Laragen Sanger Sequencing Business, Strengthening Service Continuity and Strategic Expansion in Los Angeles //
Source: https://www.prnewswire.com/news-releases/quintara-biosciences-completes-acquisition-of-laragen-sanger-sequencing-business-strengthening-service-continuity-and-strategic-expansion-in-los-angeles-302584796.html